Routine production and use of Cu-64, Zr-89, In-111 and in-house generators for: Sc-44 (PET) and Ra-223, Th-227 and Pb-212
Pass through to early phase clinical trail Clinical Translation Theranostics Center (currently operating alpha trials: 4x Pb-212 and 2x Ac-225, multiple Lu-177 studies, 1x Cu-67)